UCSF Paul Calabresi K12 Career Development Program in Clinical Oncology

加州大学旧金山分校 Paul Calabresi K12 临床肿瘤学职业发展计划

基本信息

批准号：
10368108
负责人：
EMILY K BERGSLAND
金额：
$ 42.23万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-07-01 至 2026-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10368108
关键词：
Advisory Committees Area Basic Cancer Research Biological Markers Biometry Biostatistical Methods Clinic Clinical Clinical Oncology Clinical Research Communities Competence Comprehensive Cancer Center Development Development Plans Educational Curriculum Educational workshop Ensure Environment Epidemiologic Methods Faculty Family Fostering Funding Goals Grant Health Sciences Image Individual Institutes Investigational Therapies K-Series Research Career Programs Laboratories Lead Malignant Childhood Neoplasm Malignant Neoplasms Medical Oncology Mentored Clinical Scientist Development Program Mentors Monitor NCI Center for Cancer Research Patient Outcomes Assessments Physicians Program Development Protocols documentation Radiation Oncology Research Research Methodology Research Personnel Rotation SECTM1 gene Science Scientist Series Surgical Oncology Technology Therapeutic Human Experimentation Training Training Programs Translational Research Ursidae Family Work Writing anticancer research base bench to bedside cancer clinical trial career development certificate program community engagement design drug development experience health care disparity innovation interest multidisciplinary neuro-oncology next generation patient oriented post-doctoral training programs research and development responsible research conduct skills success tool translational cancer research

项目摘要

Project Summary/Abstract The goal of the UCSF Paul Calabresi Career Development Award for Clinical Oncology is to foster the development of the next generation of clinical scientists to be effective partners with discovery scientists and conduct high impact and innovative patient-centered cancer research. The Program will be housed in the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), bringing to bear the exceptional research, clinical, and training environment of one of the world’s leading health sciences institutes. This multidisciplinary training program will leverage strengths in basic cancer research, experimental therapeutics, and clinical research methodology. Two experienced physician-scientists (one clinical researcher and one laboratory-based scientist) will direct the Program. An accomplished group of faculty will bring expertise in cancer-related clinical and translational research, imaging, patient-reported outcomes, biomarkers, healthcare disparities, community engagement, and biostatistics. Building on recent research and technology advancements and key areas for training identified in our HDFCCC strategic review, the two-year Program (which incorporates mentored research, career development guidance, and a core curriculum) is designed to facilitate completion of the year-long Advanced Training in Clinic Research certificate program in Year 1 (epidemiologic and biostatistical methods). Year 2 will focus on mentored research, professional skills, and achieving independence. An Advisory Committee (15 UCSF faculty, 6 external advisors) will work with the program directors to select up to four K12 Scholars, monitor Scholar progress, and identify opportunities for program improvement. Eligible candidates (within five years of training) will be selected from a diverse pool of UCSF faculty and well-established postdoctoral training programs in medical oncology, pediatric malignancies, neuro-oncology, radiation oncology, and surgical oncology. Each Scholar will work with at least one clinically focused and one laboratory-based mentor on their career development committee to design an individual career development plan outlining goals and tailored didactic and hands-on training experiences (including short clinical and laboratory rotations, grant-writing workshops, etc.) that will ensure competency across four core areas: (1) Clinical research methods; (2) Principles of translational cancer research and drug development; (3) Academic success skills and (4) Responsible conduct of research. New K12 program activities, including a 5-day bootcamp (Clinically Driven Discovery Science in Cancer: From the Bench to the Bedside), a seminar series (From Concept to Completion: Strategies for Successful Cancer Clinical Trials), and embedded patient-oriented cancer research experiences (e.g. scientific protocol review, presenting to the Community Advisory Board) will benefit Scholars who are directly supported by K12 funding and other UCSF faculty and trainees with an interest in clinical-translational cancer research. Upon graduation, scholars will have the tools to lead independent, rigorous, and impactful patient-centered clinical research programs.

项目概要/摘要加州大学旧金山分校保罗·卡拉布雷西临床肿瘤学职业发展奖的目标是培养培养下一代临床科学家，使其成为发现科学家的有效合作伙伴，开展高影响力和以患者为中心的创新癌症研究。加州大学旧金山分校海伦迪勒家庭综合癌症中心 (HDFCCC)，带来了卓越的世界领先的健康科学研究所之一的研究、临床和培训环境。多学科培训计划将利用基础癌症研究、实验疗法、两名经验丰富的医师科学家（一名临床研究员和一名临床研究方法）。实验室科学家）将指导该计划，一支经验丰富的教师团队将带来以下方面的专业知识。癌症相关的临床和转化研究、成像、患者报告的结果、生物标志物、医疗保健差异、社区参与和生物统计学。我们的 HDFCCC 战略审查（为期两年的计划）中确定的进展和关键培训领域（其中包括指导研究、职业发展指导和核心课程）旨在促进第一年完成为期一年的临床研究证书课程高级培训（流行病学和生物统计学方法）第二年将侧重于指导研究、专业技能和一个咨询委员会（15 名 UCSF 教职人员，6 名外部顾问）将与该委员会合作。项目主管可以选择最多四名 K12 学者、监控学者进度并寻找机会合格的候选人（培训五年内）将从多元化的人才库中选出。加州大学旧金山分校 (UCSF) 的师资队伍和完善的博士后培训项目涉及肿瘤内科、儿科恶性肿瘤、每位学者将与至少一名临床医生合作。职业发展委员会中的一名专注于实验室的导师来设计个人职业发展计划概述了目标以及量身定制的教学和实践培训经验（包括短期临床和实验室轮换、资助写作研讨会等），这将确保四个方面的能力核心领域：（1）临床研究方法；（2）转化癌症研究原理和药物发展；(3) 学术成功技能；(4) 负责任地开展新的 K12 项目。活动，包括为期 5 天的训练营（癌症中的临床驱动发现科学：从实验室到临床 Bedside），研讨会系列（从概念到完成：成功癌症临床试验的策略），并嵌入以患者为导向的癌症研究经验（例如科学方案审查、向社区咨询委员会）将使直接获得 K12 资金和其他 UCSF 资助的学者受益对临床转化癌症研究感兴趣的教员和实习生毕业后，学者们将。拥有领导独立、严谨和有影响力的以患者为中心的临床研究项目的工具。